Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
- PMID: 35618703
- PMCID: PMC9135681
- DOI: 10.1038/s41467-022-30580-5
Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
Abstract
The Omicron SARS-CoV-2 has several distinct sublineages, among which sublineage BA.1 is responsible for the initial Omicron surge and is now being replaced by BA.2 worldwide, whereas BA.3 is currently at a low frequency. The ongoing BA.1-to-BA.2 replacement underscores the importance to understand the cross-neutralization among the three Omicron sublineages. Here we test the neutralization of BA.1-infected human sera against BA.2, BA.3, and USA/WA1-2020 (a strain isolated in late January 2020). The BA.1-infected sera neutralize BA.1, BA.2, BA.3, and USA/WA1-2020 SARS-CoV-2s with geometric mean titers (GMTs) of 445, 107, 102, and 16, respectively. Thus, the neutralizing GMTs against heterologous BA.2, BA.3, and USA/WA1-2020 are 4.2-, 4.4-, and 28.4-fold lower than the GMT against homologous BA.1, respectively. These findings have implications in COVID-19 vaccine strategy.
© 2022. The Author(s).
Conflict of interest statement
X.X. and P.-Y.S. have filed a patent on the reverse genetic system. J.Z., C.K., X.X., and P.-Y.S. received compensation from Pfizer for COVID-19 vaccine development. Other authors declare no competing interests.
Figures
References
-
- Lyngse FP, et al. Transmission of SARS-CoV-2 omicron VOC subvariants BA.1 and BA.2: evidence from danish households. BioRxiv. 2022 doi: 10.1101/2022.01.28.22270044. - DOI
-
- Kurhade, C. et al. Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine. BioRxivhttps://biorxiv.org/cgi/content/short/2022.2003.2024.485633v485631 (2022).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
